L-DOPA REVERSES THE ELEVATED DENSITY OF D-2 DOPAMINE-RECEPTORS IN PARKINSONS DISEASED STRIATUM

被引：91
作者：
GUTTMAN, M
SEEMAN, P
机构：
[1] UNIV TORONTO, DEPT PHARMACOL, MED SCI BLDG, TORONTO M5S 1A8, ONTARIO, CANADA
[2] UNIV TORONTO, DEPT MED, TORONTO M5S 1A8, ONTARIO, CANADA
来源：
JOURNAL OF NEURAL TRANSMISSION | 1985年 / 64卷 / 02期
关键词：
D O I：
10.1007/BF01245971
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：93 / 103
页数：11
相关论文
共 27 条
[1]  
BIRKMAYER W, 1983, PARKINSONS DISEASE, P32
[2]   [H-3] SPIPERONE BINDING, DOPAMINE AND HVA CONCENTRATIONS IN PARKINSONS-DISEASE AND SUPRANUCLEAR PALSY [J].
BOKOBZA, B ;
RUBERG, M ;
SCATTON, B ;
JAVOYAGID, F ;
AGID, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) :167-175
[3]   L-DOPA REVERSAL OF HYPER-DOPAMINERGIC BEHAVIOR [J].
EZRINWATERS, C ;
SEEMAN, P .
LIFE SCIENCES, 1978, 22 (12) :1027-1032
[4]  
FRIEDHOFF AJ, 1977, RES COMMUN CHEM PATH, V16, P411
[5]   CHRONIC L-DOPA TREATMENT OF RATS AND MICE DOES NOT CHANGE THE SENSITIVITY OF POST-SYNAPTIC DOPAMINE-RECEPTORS [J].
JACKSON, DM ;
JENKINS, OF ;
MALOR, R ;
CHRISTIE, MJ ;
GREGORY, P .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1983, 324 (04) :271-274
[6]   RECEPTOR BASIS FOR DOPAMINERGIC SUPER-SENSITIVITY IN PARKINSONS-DISEASE [J].
LEE, T ;
SEEMAN, P ;
RAJPUT, A ;
FARLEY, IJ ;
HORNYKIEWICZ, O .
NATURE, 1978, 273 (5657) :59-61
[7]   DOPAMINE AGONISTS REVERSE THE ELEVATED H-3-NEUROLEPTIC BINDING IN NEUROLEPTIC-PRETREATED RATS [J].
LIST, SJ ;
SEEMAN, P .
LIFE SCIENCES, 1979, 24 (16) :1447-1452
[8]  
Lonnberg P., 1980, PARKINSONS DISEASE C, P93
[9]  
OLSEN RW, 1980, LIFE SCI, V27, P801
[10]   BEHAVIORAL AND BIOCHEMICAL-CHANGES FOLLOWING CHRONIC ADMINISTRATION OF L-DOPA TO RATS [J].
PYCOCK, C ;
DAWBARN, D ;
OSHAUGHNESSY, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 79 (3-4) :201-215
123